These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15500559)

  • 1. Spontaneous clearance of hepatitis C virus after long-term opiate dependence therapy with buprenorphine.
    Brunelle E; Ledru S; Rotily M; Becker C; Davion T; Vosgien V; Martinot M; Halfon P
    J Viral Hepat; 2004 Nov; 11(6):571-3. PubMed ID: 15500559
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of buprenorphine as a substitute treatment for opiate dependence in the Toxicology Clinics--introductory clinical report].
    Radomska M; Pach J; Chrostek Maj J
    Przegl Lek; 2001; 58(4):351-3. PubMed ID: 11450367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buprenorphine: a potential new treatment option for opioid dependence.
    Srivastava A; Kahan M
    CMAJ; 2006 Jun; 174(13):1835. PubMed ID: 16785455
    [No Abstract]   [Full Text] [Related]  

  • 4. Public policy statement on buprenorphine for opiate dependence and withdrawal.
    J Addict Dis; 2004; 23(4):116-7. PubMed ID: 15534969
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of opiate dependence in hands of primary care providers.
    Public Health Rep; 2003; 118(1):76. PubMed ID: 12622131
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics, bioavailability and opioid effects of liquid versus tablet buprenorphine.
    Compton P; Ling W; Moody D; Chiang N
    Drug Alcohol Depend; 2006 Mar; 82(1):25-31. PubMed ID: 16144748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Subutex is the first link in the care continuity of opiate dependence].
    Arnsvik A
    Lakartidningen; 2003 Apr; 100(15):1367. PubMed ID: 12739412
    [No Abstract]   [Full Text] [Related]  

  • 8. Subjective effects of additional doses of buprenorphine in patients on buprenorphine maintenance.
    Singhal A; Tripathi BM; Pal HR; Jena R; Jain R
    Addict Behav; 2007 Feb; 32(2):320-31. PubMed ID: 16814937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis after intravenous injection of sublingual buprenorphine in acute hepatitis C carriers: report of two cases of disappearance of viral replication after acute hepatitis.
    Peyrière H; Tatem L; Bories C; Pageaux GP; Blayac JP; Larrey D
    Ann Pharmacother; 2009 May; 43(5):973-7. PubMed ID: 19383935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mood and affect during detoxification of opiate addicts: a comparison of buprenorphine versus methadone.
    Seifert J; Metzner C; Paetzold W; Borsutzky M; Ohlmeier M; Passie T; Hauser U; Becker H; Wiese B; Emrich H; Schneider U
    Addict Biol; 2005 Jun; 10(2):157-64. PubMed ID: 16191668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative treatment and mortality correlates and adverse event profile of implant naltrexone and sublingual buprenorphine.
    Reece AS
    J Subst Abuse Treat; 2009 Oct; 37(3):256-65. PubMed ID: 19394789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New drug buprenorphine can treat patients addicted to heroin or prescription pain medications.
    Clark HW
    W V Med J; 2003; 99(1):42. PubMed ID: 12762216
    [No Abstract]   [Full Text] [Related]  

  • 13. [Buprenorphine as opioid substitution to pregnant addicts].
    Rasmussen ET; Nielsen LB
    Ugeskr Laeger; 2003 Sep; 165(38):3607-8. PubMed ID: 14556390
    [No Abstract]   [Full Text] [Related]  

  • 14. Buprenorphine for opioid dependence.
    Milne M; Crouch BI; Caravati EM
    J Pain Palliat Care Pharmacother; 2009; 23(2):153-5. PubMed ID: 19492216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buprenorphine + naloxone: new combination. Opiate dependence: no proof of reduced risk of self-administered injection.
    Prescrire Int; 2007 Dec; 16(92):232-5. PubMed ID: 18087797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
    Marsch LA; Bickel WK; Badger GJ; Stothart ME; Quesnel KJ; Stanger C; Brooklyn J
    Arch Gen Psychiatry; 2005 Oct; 62(10):1157-64. PubMed ID: 16203961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Food and Drug Administration approval of sustained-release buprenorphine for treatment of opioid dependence: realizing its potential.
    Sigmon SC; Bigelow GE
    Addiction; 2017 Mar; 112(3):386-387. PubMed ID: 27561982
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients?
    Reed LJ; Glasper A; de Wet CJ; Bearn J; Gossop M
    J Clin Psychopharmacol; 2007 Apr; 27(2):188-92. PubMed ID: 17414244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buprenorphine: effective treatment of opioid addiction starts in the office.
    Fiellin DA
    Am Fam Physician; 2006 May; 73(9):1513-4. PubMed ID: 16719242
    [No Abstract]   [Full Text] [Related]  

  • 20. Unusual presentations for pharmacotherapy-poppy seed dependence.
    Lloyd-Jones DM; Bonomo Y
    Drug Alcohol Rev; 2006 Jul; 25(4):375-6. PubMed ID: 16854666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.